ProCE Banner Activity

Where Are We Now With the Evolving Treatment Landscape for Multiple Myeloma?

Clinical Thought

A quick overview on current treatment considerations for patients with multiple myeloma at each stage of treatment.

Released: January 31, 2024

Share

Faculty

S. Vincent Rajkumar

S. Vincent Rajkumar, MD

Edward W. and Betty Knight Scripps–Edward C. Rosenow, III, MD
Professor of Medicine
Associate Editor, Mayo Clinic Proceedings
Mayo Clinic
Rochester, Minnesota

Provided by

Provided by Clinical Care Options, LLC in partnership with the International Myeloma Foundation

ProCE Banner

Supporters

Supported by educational grants from Karyopharm Therapeutics, Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme.

Karyopharm Therapeutics

Regeneron Pharmaceuticals, Inc

Sanofi Genzyme

Partners

International Myeloma Foundation

ProCE Banner

Faculty Disclosure

Primary Author

S. Vincent Rajkumar, MD

Edward W. and Betty Knight Scripps–Edward C. Rosenow, III, MD
Professor of Medicine
Associate Editor, Mayo Clinic Proceedings
Mayo Clinic
Rochester, Minnesota

S. Vincent Rajkumar, MD, has no relevant financial relationships to disclose.